Gain an Understanding of the Issues that are Driving the Transformation of the Gastrointestinal Market Today

Research and Markets has announced the addition of The Gastrointestinal Market Outlook to 2010 to their offering.

Dublin (PRWEB) March 2, 2006 -- Research and Markets (http://www.researchandmarkets.com/reports/c33691) has announced the addition of The Gastrointestinal Market Outlook to 2010 to their offering.

This report provides comprehensive coverage of the major GIT markets, incorporating a detailed epidemiological analysis of the major indications and key factors impacting their prevalence; using IMS data, it provides analysis of current leading brands of treatment within each GIT indication provides an invaluable insight into the dynamics of the market, while profiling the pharmaceutical companies and relevant market trends that influence the sales of GIT treatments.

This report further provides forecasts of major products over the 2005-10 period and the underlying trends affecting the future of the GIT market. By providing coverage of over 90% of the total market for GIT products and highlighting key players, this report allows the reader to gain a thorough understanding of the issues that are driving the transformation of the GIT market, and understand the likely direction that this market will take over the next 5 years.

About the Authors

Melissa Zebrowski

Melissa Zebrowski has 7 years of experience in healthcare and pharmaceuticals policy. During this time she has worked for 4 years as a consultant providing market research services in developed and emerging markets. Currently she is working as a pharmaceutical markets analyst.

James Fox-Tucker

James Fox-Tucker currently works as an independent healthcare consultant, and has undertaken projects on behalf of some of the largest players in both the pharmaceutical industry and the healthcare market research sector. James has previously worked as a pharmaceutical/biotech analyst in the equity research sector, as an analyst in the pharmaceutical and chemical industries, and as an advisor on public sector technology policy.

Companies Mentioned:

- AstraZeneca
- Wyeth
- Johnson & Johnson
- Amgen
- Abbott
- Takeda
- Eisai
- Novartis

For more information visit http://www.researchandmarkets.com/reports/c33691

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###